NIH Closes Doors for April Grant Review Sessions
Published Date: 3/19/2025
Notice
Summary
The Center for Scientific Review at the NIH is holding several closed virtual meetings in April 2025 to review and evaluate grant applications. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers applying for grants and those interested in health studies should note these dates, as they impact funding decisions but don’t involve new costs or changes.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Grant Applications Will Be Reviewed on Listed Dates
Several Center for Scientific Review panels will review and evaluate NIH grant applications on specific dates in April and May 2025, including April 10; April 16; April 18; April 22–24; April 24; April 30; May 1–2; May 1; May 6; and May 12, 2025. These reviews influence funding decisions for applicants but do not introduce new costs or regulatory changes.
NIH Review Meetings Closed to Public
The NIH Center for Scientific Review is holding multiple closed meetings in April and May 2025 (starting April 10, 2025 and ending May 12, 2025) that are not open to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6). This means members of the public cannot attend these panels while they review grant applications.
Applicant Confidentiality and Trade Secrets Protected
The meetings are closed because the grant applications and discussions could disclose confidential trade secrets, patentable material, or personal information about individuals associated with applications. Closing the meetings protects applicants' proprietary information and personal privacy under the cited statutes.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17687, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in October 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, ensuring fair and confidential decisions. Scientists applying for grants in genetics, molecular sciences, oral health, and cancer research are the ones affected, with no direct cost changes announced.
2026-17438, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings in late September 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers applying for funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
Previous / Next Documents
Previous: 2025-04621, New Postal Products
The Postal Service just filed a new deal for special mail services, and the Commission is checking it out. This affects businesses and customers who use these special mail options, with possible changes in prices or services soon. The public can share their thoughts before any final decisions are made.
Next: 2025-04623, National Center for Advancing Translational Sciences; Notice of Closed Meetings
The National Center for Advancing Translational Sciences is holding a closed video meeting from April 22-24, 2025, to review special grant applications. These meetings are private to protect secret business info and personal details. Researchers applying for funding will be affected, but no new costs or deadlines are announced.